Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

International Journal of Inflammation - United States
doi 10.1155/2013/156905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

New Aspects of Thromboangiitis Obliterans (Von Winiwarter-Buerger’s Disease)

European Neurology
Neurology
1984English

Thromboangiitis Obliterans (Buerger's Disease)

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2006English

Thromboangiitis Obliterans

Current Treatment Options in Rheumatology
RheumatologyAllergyImmunology
2016English

Thromboangiitis Obliterans

2016English

Thromboangiitis Obliterans

British Journal of Surgery
Surgery
1969English

Thromboangiitis Obliterans

2016English

Thromboangiitis Obliterans

2013English

Treatment of Buerger’s Disease (Thromboangiitis Obliterans) With Autologous Adipose Tissue-Derived Mesenchymal Stem Cell: Report of Three Cases

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Pyridinolcarbamate; Bradykinin Antagonist, in Patients Suffering From Arteriosclerosis Obliterans and Thromboangiitis Obliterans (Buerger's Disease)

Japanese Heart Journal
1965English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy